| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |